CMRA logo

Comera Life Sciences Holdings (CMRA) Financials

Balance sheets

30 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 202230 June 202231 Mar 202201 Dec 202130 Sept 202130 June 2021

Total Assets

$3.1 M(+31.3%)$2.3 M(-22.0%)$3.0 M(-19.5%)$3.7 M(-24.5%)$4.9 M(-19.5%)$6.1 M-$7.4 M--

Current Assets

$2.6 M(+44.2%)$1.8 M(-24.2%)$2.4 M(-21.4%)$3.1 M(-28.6%)$4.3 M(-20.7%)$5.4 M-$6.8 M--

Non Current Assets

$441.5 K(-14.4%)$516.1 K(-12.8%)$591.7 K(-10.9%)$664.0 K(+2.4%)$648.2 K(-9.9%)$719.8 K-$636.7 K--

Total Liabilities

$7.3 M(-16.1%)$8.7 M(+5.2%)$8.3 M(-17.1%)$10.0 M(+19.2%)$8.4 M(+5.6%)$7.9 M-$22.1 M--

Current Liabilities

$2.9 M(-25.8%)$4.0 M(+17.8%)$3.4 M(-33.7%)$5.1 M(+47.5%)$3.4 M(+35.9%)$2.5 M-$1.0 M--

Long Term Liabilities

$4.4 M(-8.0%)$4.7 M(-3.5%)$4.9 M(-0.1%)$4.9 M(-0.4%)$4.9 M(-8.6%)$5.4 M-$21.1 M--

Shareholders Equity

-$4.2 M(+33.5%)-$6.4 M(-20.6%)-$5.3 M(+15.7%)-$6.2 M(-82.2%)-$3.4 M(-91.3%)-$1.8 M--$14.7 M--

Book Value

-$4.2 M(+33.5%)-$6.4 M(-20.6%)-$5.3 M(+15.7%)-$6.2 M(-82.2%)-$3.4 M(-91.3%)-$1.8 M--$14.7 M--

Working Capital

-$301.9 K(+85.8%)-$2.1 M(-124.7%)-$947.6 K(+52.5%)-$2.0 M(-332.4%)$858.8 K(-70.3%)$2.9 M-$5.7 M--

Cash And Cash Equivalents

$1.8 M(+271.2%)$476.3 K(-69.0%)$1.5 M(+244.5%)$446.6 K(-83.3%)$2.7 M(-46.0%)$4.9 M-$6.5 M--

Accounts Payable

$1.1 M(-46.8%)$2.2 M(+21.4%)$1.8 M(+21.5%)$1.5 M(+1.5%)$1.4 M(+0.8%)$1.4 M-$416.9 K--

Accounts Receivable

$0.0(-100.0%)$250.0 K(+100.0%)$0.0(-100.0%)$34.3 K(-88.3%)$293.8 K(+193.8%)$100.0 K-$0.0--

Short Term Debt

$171.6 K(-22.7%)$221.9 K(+2.0%)$217.5 K(+9.2%)$199.2 K(+2.0%)$195.3 K(+2.0%)$191.4 K-$121.6 K--

Long Term Debt

$0.0(0%)$0.0(-100.0%)$53.7 K(-55.4%)$120.3 K(-29.9%)$171.6 K(-22.7%)$221.9 K-$201.5 K--

Total Debt

$171.6 K(-22.7%)$221.9 K(-18.2%)$271.2 K(-15.1%)$319.5 K(-12.9%)$366.9 K(-11.2%)$413.3 K(+100.0%)$0.0(-100.0%)$323.1 K(+100.0%)$0.0(0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0-0.0--

Current Ratio

0.9(+95.7%)0.5(-36.1%)0.7(+18.0%)0.6(-51.2%)1.3(-41.6%)2.1-6.5--

Quick Ratio

----------

Inventory

----------

Retained Earnings

-$41.0 M(-5.5%)-$38.8 M(-3.8%)-$37.4 M(-7.1%)-$34.9 M(-9.3%)-$31.9 M(-10.7%)-$28.9 M--$16.9 M--

PB Ratio

-2.1(-12.0%)-1.9(+53.5%)-4.1(-24.9%)-3.3(+59.7%)-8.2(+71.0%)-28.1----

Income statements

30 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 202230 June 202231 Mar 202201 Dec 202130 Sept 202130 June 2021

EPS

-$0.1(-25.0%)-$0.1(+38.5%)-$0.1(+28.7%)-$0.2(+8.8%)-$0.2(+82.5%)-$1.1(-655.5%)-$0.2(-42.4%)-$0.1(-121.3%)-$0.0(+53.9%)-$0.1

TTM EPS

-$0.5(+16.9%)-$0.6(+64.2%)-$1.7(+1.3%)-$1.7(-4.8%)-$1.6(-10.5%)-$1.4(-253.6%)-$0.4(-58.6%)-$0.3(-69.9%)-$0.2(-46.1%)-$0.1

Revenue

$136.3 K(-56.7%)$315.1 K(-19.8%)$392.9 K(+151.7%)$156.1 K(-33.5%)$234.9 K(+60.1%)$146.7 K(+53.9%)$95.3 K(+30.0%)$73.3 K(-16.5%)$87.8 K(+23.8%)$70.9 K

TTM Revenue

$1.0 M(-9.0%)$1.1 M(+18.1%)$930.6 K(+47.0%)$633.0 K(+15.1%)$550.2 K(+36.5%)$403.1 K(+23.2%)$327.3 K(+41.1%)$232.0 K(+46.2%)$158.7 K(+123.8%)$70.9 K

Total Expenses

$2.3 M(+27.7%)$1.8 M(-38.0%)$2.9 M(-8.6%)$3.2 M(+14.3%)$2.8 M(-32.8%)$4.1 M(+61.7%)$2.5 M(+21.5%)$2.1 M(+109.4%)$1.0 M(-49.3%)$2.0 M

Operating Expenses

$2.3 M(+29.4%)$1.7 M(-37.4%)$2.8 M(-10.8%)$3.1 M(+15.0%)$2.7 M(-33.4%)$4.1 M(+62.4%)$2.5 M(+21.6%)$2.1 M(+116.0%)$953.1 K(-50.3%)$1.9 M

Cost Of Goods Sold

$42.0 K(-25.0%)$56.0 K(-51.9%)$116.5 K(+131.2%)$50.4 K(-17.4%)$61.0 K(+11.9%)$54.5 K(+22.5%)$44.5 K(+14.4%)$38.9 K(-19.6%)$48.4 K(-16.0%)$57.6 K

TTM Cost Of Goods Sold

$264.9 K(-6.7%)$283.9 K(+0.5%)$282.4 K(+34.2%)$210.4 K(+5.8%)$198.9 K(+6.8%)$186.3 K(-1.6%)$189.4 K(+30.7%)$144.9 K(+36.7%)$106.0 K(+84.0%)$57.6 K

Gross Profit

$94.3 K(-63.6%)$259.0 K(-6.3%)$276.4 K(+161.3%)$105.8 K(-39.2%)$174.0 K(+88.7%)$92.2 K(+81.5%)$50.8 K(+47.7%)$34.4 K(-12.7%)$39.4 K(+194.0%)$13.4 K

TTM Gross Profit

$735.5 K(-9.8%)$815.2 K(+25.7%)$648.4 K(+53.4%)$422.8 K(+20.3%)$351.4 K(+62.1%)$216.8 K(+57.1%)$138.0 K(+58.3%)$87.2 K(+65.2%)$52.8 K(+294.0%)$13.4 K

Gross Margin

69.2%(-15.8%)82.2%(+16.9%)70.3%(+3.9%)67.7%(-8.5%)74.0%(+17.9%)62.8%(+17.9%)53.3%(+13.6%)46.9%(+4.5%)44.9%(+138.6%)18.8%

Operating Profit

-$2.2 M(-45.7%)-$1.5 M(+40.8%)-$2.5 M(+16.9%)-$3.0 M(-18.7%)-$2.5 M(+36.2%)-$4.0 M(-62.0%)-$2.5 M(-21.2%)-$2.0 M(-121.5%)-$913.7 K(+52.0%)-$1.9 M

TTM Operating Profit

-$9.1 M(+4.0%)-$9.5 M(+20.7%)-$12.0 M(-0.4%)-$12.0 M(-9.0%)-$11.0 M(-17.3%)-$9.4 M(-28.4%)-$7.3 M(-50.7%)-$4.8 M(-71.8%)-$2.8 M(-48.0%)-$1.9 M

Operating Margin

-1582.5%(-236.8%)-469.8%(+26.2%)-636.4%(+67.0%)-1927.4%(-78.6%)-1079.3%(+60.1%)-2707.7%(-5.3%)-2572.7%(+6.8%)-2760.1%(-165.1%)-1041.0%(+61.2%)-2684.6%

Net Income

-$2.2 M(-52.6%)-$1.4 M(+43.1%)-$2.5 M(+16.3%)-$3.0 M(+3.7%)-$3.1 M(+66.1%)-$9.1 M(-215.5%)-$2.9 M(-42.3%)-$2.0 M(-121.5%)-$913.7 K(+53.9%)-$2.0 M

TTM Net Income

-$9.0 M(+9.3%)-$9.9 M(+43.6%)-$17.6 M(+2.2%)-$18.0 M(-5.5%)-$17.1 M(-14.5%)-$14.9 M(-91.1%)-$7.8 M(-58.5%)-$4.9 M(-69.9%)-$2.9 M(-46.1%)-$2.0 M

Net Margin

-1580.0%(-252.6%)-448.1%(+29.1%)-631.5%(+66.7%)-1897.6%(-44.9%)-1309.7%(+78.8%)-6192.0%(-105.0%)-3020.3%(-9.4%)-2760.1%(-165.1%)-1041.0%(+62.7%)-2792.8%

EBIT

-$2.1 M(-52.6%)-$1.4 M(+43.1%)-$2.5 M(+16.3%)-$3.0 M(+3.6%)-$3.1 M(+66.3%)-$9.1 M(-215.5%)-$2.9 M(-42.3%)-$2.0 M(-121.5%)-$913.7 K(+53.9%)-$2.0 M

TTM EBIT

-$9.0 M(+9.3%)-$9.9 M(+43.7%)-$17.6 M(+2.3%)-$18.0 M(-5.5%)-$17.1 M(-14.4%)-$14.9 M(-91.1%)-$7.8 M(-58.5%)-$4.9 M(-69.9%)-$2.9 M(-46.1%)-$2.0 M

EBITDA

-$2.1 M(-53.7%)-$1.4 M(+43.5%)-$2.4 M(+16.6%)-$2.9 M(+3.6%)-$3.0 M(+66.5%)-$9.1 M(-217.5%)-$2.9 M(-42.7%)-$2.0 M(-123.6%)-$894.5 K(+54.8%)-$2.0 M

TTM EBITDA

-$8.9 M(+9.3%)-$9.8 M(+43.9%)-$17.5 M(+2.3%)-$17.9 M(-5.5%)-$17.0 M(-14.5%)-$14.8 M(-91.6%)-$7.7 M(-58.5%)-$4.9 M(-69.6%)-$2.9 M(-45.2%)-$2.0 M

Selling, General & Administrative Expenses

$1.9 M(+25.4%)$1.5 M(-38.2%)$2.4 M(-7.3%)$2.6 M(+13.4%)$2.3 M(-37.4%)$3.7 M(+83.3%)$2.0 M(+28.6%)$1.6 M(+127.4%)$689.5 K(-44.3%)$1.2 M

TTM SG&A

$8.4 M(-4.8%)$8.9 M(-19.8%)$11.1 M(+3.9%)$10.7 M(+11.0%)$9.6 M(+20.4%)$8.0 M(+44.6%)$5.5 M(+57.7%)$3.5 M(+81.4%)$1.9 M(+55.7%)$1.2 M

Depreciation And Amortization

$23.0 K(-7.3%)$24.8 K(-12.4%)$28.3 K(+18.9%)$23.8 K(0%)$23.8 K(+10.2%)$21.6 K(-12.9%)$24.8 K---

TTM D&A

$99.9 K(-0.8%)$100.7 K(+3.3%)$97.5 K(+3.7%)$94.0 K(+33.9%)$70.2 K(+51.3%)$46.4 K(+87.1%)$24.8 K---

Interest Expense

$6000.0(+50.0%)$4000.0(-47.4%)$7600.0(0%)$7600.0(-40.2%)$12.7 K(+100.0%)$0.0(-100.0%)$100.0(+100.0%)$0.0(0%)$0.0(0%)$0.0

TTM Interest Expense

$25.2 K(-21.0%)$31.9 K(+14.3%)$27.9 K(+36.8%)$20.4 K(+59.4%)$12.8 K(+12700.0%)$100.0(0%)$100.0(+100.0%)$0.0(0%)$0.0(0%)$0.0

Income Tax

----------

TTM Income Tax

----------

PE Ratio

----------

PS Ratio

9.0(-18.2%)11.0(-52.6%)23.3(-28.4%)32.5(-36.1%)50.9(-59.3%)125.0----

Cashflow statements

30 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 202230 June 202231 Mar 202201 Dec 202130 Sept 202130 June 2021

Cash From Operations

-$1.9 M(-92.7%)-$993.5 K(+47.9%)-$1.9 M(-3.1%)-$1.8 M(+22.7%)-$2.4 M(+10.3%)-$2.7 M(+7.1%)-$2.9 M---

TTM CFO

-$6.7 M(+6.7%)-$7.1 M(+19.0%)-$8.8 M(+9.9%)-$9.8 M(-23.3%)-$7.9 M(-43.2%)-$5.5 M(-92.9%)-$2.9 M---

Cash From Investing

$0.0(+100.0%)-$5600.0(+93.7%)-$88.4 K(-100.0%)$0.0(+100.0%)-$25.2 K(-620.0%)-$3500.0(-100.0%)$0.0---

TTM CFI

-$94.0 K(+21.1%)-$119.2 K(-1.8%)-$117.1 K(-308.0%)-$28.7 K(0%)-$28.7 K(-720.0%)-$3500.0(-100.0%)$0.0---

Cash From Financing

$3.2 M(+5172.1%)-$63.2 K(-104.0%)$1.6 M(+39.8%)$1.1 M(+678.6%)$145.2 K(-96.1%)$3.7 M(+1582.7%)$222.5 K---

TTM CFF

$5.9 M(+109.6%)$2.8 M(-57.7%)$6.6 M(+25.9%)$5.2 M(+27.5%)$4.1 M(+3.7%)$4.0 M(+1682.7%)$222.5 K---

Free Cash Flow

-$1.9 M(-91.5%)-$999.2 K(+49.9%)-$2.0 M(-7.9%)-$1.8 M(+23.5%)-$2.4 M(+9.5%)-$2.7 M(+7.0%)-$2.9 M---

TTM FCF

-$6.8 M(+6.9%)-$7.3 M(+18.7%)-$8.9 M(+8.9%)-$9.8 M(-23.2%)-$8.0 M(-43.6%)-$5.5 M(-93.0%)-$2.9 M---

CAPEX

$0.0(-100.0%)$5600.0(-93.7%)$88.4 K(+100.0%)$0.0(-100.0%)$25.2 K(+620.0%)$3500.0----

TTM CAPEX

$94.0 K(-21.1%)$119.2 K(+1.8%)$117.1 K(+308.0%)$28.7 K(0%)$28.7 K(+720.0%)$3500.0----

Dividends Paid

----------

TTM Dividends Paid

----------

TTM Dividend Per Share

----------

TTM Dividend Yield

----------

Payout Ratio

----------